| Melissa H Tukey, MD | |
|
55 Lake Ave N, Worcester, MA 01655-0002 | |
| (508) 856-1975 | |
| Not Available |
| Full Name | Melissa H Tukey |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 55 Lake Ave N, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053578963 | NPI | - | NPPES |
| 110088439A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 240050 (Massachusetts) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 240050 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.
Omeros Corporation today announced the initiation of the planned pharmacokinetic (PK) substudy in its Phase 3 clinical program evaluating OMS302 in patients undergoing intraocular lens replacement (ILR) surgery.
Professional baseball players struggle to return to a high level of play after biceps tenodesis (BP) surgery, according to research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego. The study examined how players with SLAP tears responded to biceps tenodesis.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
› Verified 8 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.
Omeros Corporation today announced the initiation of the planned pharmacokinetic (PK) substudy in its Phase 3 clinical program evaluating OMS302 in patients undergoing intraocular lens replacement (ILR) surgery.
Professional baseball players struggle to return to a high level of play after biceps tenodesis (BP) surgery, according to research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego. The study examined how players with SLAP tears responded to biceps tenodesis.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa H Tukey, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Melissa H Tukey, MD 55 Lake Ave N, Worcester, MA 01655-0002 Ph: (508) 856-1975 |
News Archive
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.
Omeros Corporation today announced the initiation of the planned pharmacokinetic (PK) substudy in its Phase 3 clinical program evaluating OMS302 in patients undergoing intraocular lens replacement (ILR) surgery.
Professional baseball players struggle to return to a high level of play after biceps tenodesis (BP) surgery, according to research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego. The study examined how players with SLAP tears responded to biceps tenodesis.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
› Verified 8 days ago
Dr. Adepeju Gbadebo Champion, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-2731 Fax: 774-442-4672 | |
Madaiah Lokeshwari, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-6849 | |
Sowmya Korapati, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-3550 Fax: 774-442-6715 | |
Irma Hashmi, DO Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Madhav Sharma, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-5438 | |
Daniel M Steigman, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 123 Summer Street, Suite 390, Worcester, MA 01608 Phone: 508-368-3120 Fax: 508-368-3121 | |
Dr. Julia D Andrieni, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Department Of General Medicine, Worcester, MA 01655 Phone: 508-334-2731 |